PSTV - Why Is Cancer Diagnostic Focused Biocept Stock Trading Higher Today? | Benzinga
Biocept Inc (NASDAQ: BIOC) shares are trading higher after the company signed a non-exclusive licensing agreement for CNSide with Plus Therapeutics Inc (NASDAQ: PSTV), which expands the comprehensive laboratory services agreement between the two companies that was announced in June 2022.
Benzinga exclusively broke the story.
Plus Therapeutics is using CNSide in a clinical trial with their targeted radiotherapeutic ...